Programme
Accelerate Alumni (Cohort 15)
Founded in
2017
Total funds raised
£2.5 million
Employees
1-10
Industry
Healthcare, pharma, biotech
Upfront Diagnostics has discovered and validated novel blood biomarkers for the detection of stroke patients suffering from a large vessel occlusion. Biomarkers enable faster and more accurate stroke diagnosis which will decrease the time to treatment, reducing disabilities and deaths after a stroke. Upfront Diagnostics owns a family of patentswhich protects novel biomarkers for stroke detection.
Get in touch
Press coverage on Upfront Diagnostics
Business Weekly | 12 May 2025
Upfront clinches $4.3m to advance stroke test in UK, US and elsewhere
Accelerate Alumni raises $4.3m to accelerate commercialisation of revolutionary stroke blood test.